logo

Is there any clinical evidence that andrographis is effective against the coronavirus?

Thursday, May 28, 2020
By William Boger
NO

Traditional Chinese medicine has been deployed against COVID-19, despite a lack of reliable clinical studies of the type used to prove the safety and efficacy of new products from the international pharmaceutical industry.

Andrographis, a plant native to South Asia, is often used against ordinary flu. In a 2014 study, extracts and compounds showed "significant" returns in anti-inflammatory, anti-allergic, and immunostimulant tests. A 2017 study showed that compounds from the plant formed a foundation to "restrain virus replication and virus-induced [pathogens]." In May, a computer simulation revealed that the related chemical compound andrographolide showed potential against the inhibitor region of the main protease of the coronavirus.

There are as yet no practical studies or human trials of andrographis' direct effect on the coronavirus.

This fact brief is responsive to conversations such as this one.
ABOUT THE CONTRIBUTOR
Between 2020 and 2022, under close editorial supervision, Gigafact contracted a group of freelance writers and editors to test the concepts for fact briefs and provide inputs to our software development process. We call this effort Gigafact Foundry. Over the course of these two years, Gigafact Foundry writers published over 1500 fact briefs in response to claims they found online. Their important work forms the basis of Gigafact formats and editorial guidelines, and is available to the public on Gigafact.org. Readers should be aware that while there is still a lot of relevant information to be found, not all fact briefs produced by Gigafact Foundry reflect Gigafact's current methods and standards for fact briefs. If you come across any that you feel are out of date and need to be looked at with fresh eyes, don't hesitate to contact us at support@gigafact.org.
FACT BRIEF BY
facebook
twitter
email
email